Bruce W. Penman

4.7k total citations · 2 hit papers
38 papers, 3.9k citations indexed

About

Bruce W. Penman is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Bruce W. Penman has authored 38 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Cancer Research and 12 papers in Pharmacology. Recurrent topics in Bruce W. Penman's work include Carcinogens and Genotoxicity Assessment (16 papers), DNA Repair Mechanisms (12 papers) and Pharmacogenetics and Drug Metabolism (12 papers). Bruce W. Penman is often cited by papers focused on Carcinogens and Genotoxicity Assessment (16 papers), DNA Repair Mechanisms (12 papers) and Pharmacogenetics and Drug Metabolism (12 papers). Bruce W. Penman collaborates with scholars based in United States and Israel. Bruce W. Penman's co-authors include Charles L. Crespi, William F. Busby, Arthur L. Lafleur, John L. Durant, William G. Thilly, Tam T. Nguyen, Steven R. Tannenbaum, J S Wishnok, Vaughn P. Miller and Howard L. Liber and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Environmental Science & Technology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Bruce W. Penman

38 papers receiving 3.7k citations

Hit Papers

DNA damage and mutation i... 1992 2026 2003 2014 1992 1996 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce W. Penman United States 25 1.3k 1.0k 848 816 577 38 3.9k
Jeroen Buters Germany 39 1.4k 1.0× 1.3k 1.2× 522 0.6× 1.6k 2.0× 1.2k 2.1× 131 5.6k
Bengt Jernström Sweden 30 2.1k 1.6× 2.1k 2.1× 1.3k 1.6× 538 0.7× 392 0.7× 116 5.0k
R. T. Williams United Kingdom 40 1.5k 1.1× 344 0.3× 426 0.5× 1.0k 1.2× 869 1.5× 155 5.1k
M. W. Anders United States 33 1.5k 1.2× 448 0.4× 453 0.5× 625 0.8× 489 0.8× 97 3.3k
Lisa M. Kamendulis United States 28 1.7k 1.3× 584 0.6× 695 0.8× 515 0.6× 424 0.7× 60 4.3k
Kendall B. Wallace United States 50 2.7k 2.1× 1.5k 1.5× 366 0.4× 189 0.2× 997 1.7× 121 7.5k
Hanspeter Witschi United States 35 1.3k 1.0× 591 0.6× 763 0.9× 344 0.4× 402 0.7× 134 3.8k
Charles L. Crespi United States 44 2.4k 1.9× 1.2k 1.2× 1.3k 1.5× 3.5k 4.3× 1.9k 3.3× 97 7.8k
Stephen Ferguson United States 38 1.6k 1.3× 1.1k 1.1× 572 0.7× 1.6k 1.9× 795 1.4× 108 5.1k
Bhagavatula Moorthy United States 35 1.3k 1.0× 879 0.9× 741 0.9× 741 0.9× 350 0.6× 152 4.2k

Countries citing papers authored by Bruce W. Penman

Since Specialization
Citations

This map shows the geographic impact of Bruce W. Penman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce W. Penman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce W. Penman more than expected).

Fields of papers citing papers by Bruce W. Penman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce W. Penman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce W. Penman. The network helps show where Bruce W. Penman may publish in the future.

Co-authorship network of co-authors of Bruce W. Penman

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce W. Penman. A scholar is included among the top collaborators of Bruce W. Penman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce W. Penman. Bruce W. Penman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pedersen, D., John L. Durant, Bruce W. Penman, et al.. (2003). Human-Cell Mutagens in Respirable Airborne Particles in the Northeastern United States. 1. Mutagenicity of Fractionated Samples. Environmental Science & Technology. 38(3). 682–689. 66 indexed citations
2.
Durant, John L., et al.. (2001). Human cell mutagenicity of chlorinated and unchlorinated water and the disinfection byproduct 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX). Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 495(1-2). 157–168. 20 indexed citations
3.
Durant, John L., et al.. (1999). Mutagenicity of C24H14 PAH in human cells expressing CYP1A1. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 446(1). 1–14. 96 indexed citations
4.
Hu, Ming, Yiqi Li, Christine M. Davitt, et al.. (1999). Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase.. Pharmaceutical Research. 16(9). 1352–1359. 47 indexed citations
5.
Hannigan, Michael, Glen R. Cass, Bruce W. Penman, et al.. (1998). Bioassay-Directed Chemical Analysis of Los Angeles Airborne Particulate Matter Using a Human Cell Mutagenicity Assay. Environmental Science & Technology. 32(22). 3502–3514. 125 indexed citations
6.
Code, Erin, Charles L. Crespi, Bruce W. Penman, et al.. (1997). Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.. PubMed. 25(8). 985–93. 212 indexed citations
7.
Crespi, Charles L. & Bruce W. Penman. (1997). Use of cDNA-Expressed Human Cytochrome P450 Enzymes to Study Potential Drug-Drug Interactions. Advances in pharmacology. 43. 171–188. 101 indexed citations
8.
Crespi, Charles L., Vaughn P. Miller, & Bruce W. Penman. (1997). Microtiter Plate Assays for Inhibition of Human, Drug-Metabolizing Cytochromes P450. Analytical Biochemistry. 248(1). 188–190. 345 indexed citations
9.
Busby, William F., et al.. (1997). Mutagenicity of the atmospheric transformation products 2-nitrofluoranthene and 2-nitrodibenzopyranone in Salmonella and human cell forward mutation assays. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 389(2-3). 261–270. 9 indexed citations
10.
Durant, John L., William F. Busby, Arthur L. Lafleur, Bruce W. Penman, & Charles L. Crespi. (1996). Human cell mutagenicity of oxygenated, nitrated and unsubstituted polycyclic aromatic hydrocarbons associated with urban aerosols. Mutation Research/Genetic Toxicology. 371(3-4). 123–157. 713 indexed citations breakdown →
11.
Busby, William F., et al.. (1995). Mutagenicity of benzo[a]pyrene and dibenzopyrenes in the Salmonella typhimurium TM677 and the MCL-5 human cell forward mutation assays. Mutation Research/Genetic Toxicology. 342(1-2). 9–16. 67 indexed citations
12.
Busby, William F., Bruce W. Penman, & Charles L. Crespi. (1994). Human cell mutagenicity of mono- and dinitropyrenes in metabolically competent MCL-5 cells. Mutation Research/Genetic Toxicology. 322(4). 233–242. 39 indexed citations
13.
Nguyen, Tam T., et al.. (1992). DNA damage and mutation in human cells exposed to nitric oxide in vitro.. Proceedings of the National Academy of Sciences. 89(7). 3030–3034. 806 indexed citations breakdown →
14.
Crespi, Charles L., Bruce W. Penman, Dorothy T. Steimel, Harry V. Gelboin, & Frank J. Gonzalez. (1991). The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3. Carcinogenesis. 12(2). 355–359. 107 indexed citations
15.
Crespi, Charles L., et al.. (1990). Sodium fluoride is a less efficient human cell mutagen at low concentrations. Environmental and Molecular Mutagenesis. 15(2). 71–77. 21 indexed citations
16.
Caspary, William J., Robert Langenbach, Bruce W. Penman, et al.. (1988). The mutagenic activity of selected compounds at the TK locus: Rodent vs. human cells. Mutation Research/Reviews in Genetic Toxicology. 196(1). 61–81. 24 indexed citations
17.
Penman, Bruce W. & Charles L. Crespi. (1987). Analysis of human lymphoblast mutation assays by using historical negative control data bases. Environmental and Molecular Mutagenesis. 10(1). 35–60. 27 indexed citations
18.
Penman, Bruce W., Debra A. Kaden, Howard L. Liber, et al.. (1980). Perylene is a more potent mutagen than benzo[α]pyrene for S. typhimurium. Mutation Research/Genetic Toxicology. 77(3). 271–277. 6 indexed citations
19.
Penman, Bruce W., Heinrich C. Hoppe, & William G. Thilly. (1979). Concentration-Dependent Mutation by Alkylating Agents in Human Lymphoblasts and <italic>Salmonella typhimurium: N</italic>-Methyl-<italic>N</italic>-nitrosourethane and β-Propiolactone<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 63(4). 903–7. 7 indexed citations
20.
Thilly, William G., John G. DeLuca, H. Hoppe, & Bruce W. Penman. (1978). Phenotypic lag and mutation to 6-thioguanine resistance in diploid human lymphoblasts. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 50(1). 137–144. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026